Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5532)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rambach L, Bertaut A, Vincent J, Lorgis V, Ladoire S, Ghiringhelli F. Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patients. World J Gastroenterol 2014; 20(6): 1565-1573 [PMID: 24587632 DOI: 10.3748/wjg.v20.i6.1565] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i6/1565.htm |
| Number | Citing Articles |
| 1 |
Yang Chen, YanRong Wang, Yan Shi, GuangHai Dai. Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6 -treated patients. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3240-6
|
| 2 |
Yassine Lalami, Jean Klastersky. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data. Critical Reviews in Oncology/Hematology 2017; 120: 163 doi: 10.1016/j.critrevonc.2017.11.005
|
| 3 |
Binaya Sapkota, Ronash Shrestha, Safin Chapagai, Dip Kiran Shakya, Prashant Bista. <p>Validation of Risk of Chemotherapy-Induced Neutropenia: Experience from Oncology Hospital of Nepal</p>. Cancer Management and Research 2020; : 3751 doi: 10.2147/CMAR.S243916
|
| 4 |
Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set. ESMO Open 2018; 3(3): e000347 doi: 10.1136/esmoopen-2018-000347
|
| 5 |
Giuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri. Leukocyte kinetics during the first cycle of chemotherapy predicts the outcome of patients with metastatic colorectal cancer and previous resection of the primary tumor. International Journal of Colorectal Disease 2021; 36(4): 847 doi: 10.1007/s00384-020-03815-4
|
| 6 |
Rui-Min Ma, Chuan-Zhi Chen, Wei Zhang, Jie You, Du-Ping Huang, Gui-Long Guo. Prognostic Value of Chemotherapy-Induced Neutropenia at the First Cycle in Invasive Breast Cancer. Medicine 2016; 95(13): e3240 doi: 10.1097/MD.0000000000003240
|
| 7 |
Are Kristensen, Tora Skeidsvoll Solheim, Øystein Fløtten, Bjørn Henning Grønberg. Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials. Acta Oncologica 2018; 57(11): 1574 doi: 10.1080/0284186X.2018.1492151
|
| 8 |
XiangZhou Tan, QiaoCheng Wen, Ran Wang, ZhiKang Chen. Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies. Expert Review of Anticancer Therapy 2017; 17(11): 1077 doi: 10.1080/14737140.2017.1380521
|
| 9 |
Yijing He, Ting Li, Jue Liu, Qiong Ou, Junlin Zhou. Early onset neutropenia: a useful predictor of chemosensitivity and favorable prognosis in patients with serous ovarian cancer. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6609-x
|
| 10 |
Rujiao Liu, Mingzhu Huang, Xiaoying Zhao, Wei Peng, Si Sun, Jun Cao, Dongmei Ji, Chenchen Wang, Weijian Guo, Jin Li, Jiliang Yin, Xiaodong Zhu. Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen. Oncotarget 2015; 6(36): 39018 doi: 10.18632/oncotarget.5730
|
| 11 |
Ralf‐Dieter Hofheinz, Carsten Lange, Thorsten Ecke, Susanne Kloss, Burkhard Linsse, Christine Windemuth‐Kieselbach, Peter Hammerer, Salah‐Eddin Al‐Batran. Quality of life and pain relief in men with metastatic castration‐resistant prostate cancer on cabazitaxel: the non‐interventional ‘QoLiTime’ study. BJU International 2017; 119(5): 731 doi: 10.1111/bju.13658
|
| 12 |
Leila Family, Lanfang Xu, Hairong Xu, Kimberly Cannavale, Olivia Sattayapiwat, John H. Page, Chet Bohac, Chun Chao. The effect of chemotherapy-induced anemia on dose reduction and dose delay. Supportive Care in Cancer 2016; 24(10): 4263 doi: 10.1007/s00520-016-3258-3
|
| 13 |
Masashi Yahagi, Masashi Tsuruta, Hirotoshi Hasegawa, Koji Okabayashi, Yuko Kitagawa. Non-alcoholic fatty liver disease fibrosis score predicts hematological toxicity of chemotherapy including irinotecan for colorectal cancer. Molecular and Clinical Oncology 2017; 6(4): 529 doi: 10.3892/mco.2017.1177
|
| 14 |
Megan Crumbaker, Howard Gurney. Dose considerations for anti-cancer drugs in metastatic prostate cancer. The Prostate 2017; 77(11): 1199 doi: 10.1002/pros.23378
|
| 15 |
Guanghua Li, Zhao Wang, Jianbo Xu, Hui Wu, Shirong Cai, Yulong He. The prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2276-3
|
| 16 |
Dhanusha Sabanathan, Alison Zhang, Peter Fox, Sally Coulter, Val Gebski, Bavanthi Balakrishnar, Mathew Chan, Christopher Liddle, Howard Gurney. Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring. Cancer Chemotherapy and Pharmacology 2017; 80(2): 385 doi: 10.1007/s00280-017-3362-1
|
| 17 |
Lennard Y. W. Lee, Thomas Starkey, Shivan Sivakumar, Susan Fotheringham, Guy Mozolowski, Vanessa Shearwood, Claire Palles, Philip Camilleri, David Church, Rachel Kerr, David Kerr. ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study. Cancer Medicine 2019; 8(14): 6305 doi: 10.1002/cam4.2529
|
| 18 |
Fumiaki Yamashita, Ikumi Komoto, Hiroaki Oka, Keizo Kuwata, Mayuko Takeuchi, Fumio Nakagawa, Kunihiro Yoshisue, Masato Chiba. Exposure-dependent incorporation of trifluridine into DNA of tumors and white blood cells in tumor-bearing mouse. Cancer Chemotherapy and Pharmacology 2015; 76(2): 325 doi: 10.1007/s00280-015-2805-9
|
| 19 |
Alexander Meisel, Stefanie von Felten, Deborah R. Vogt, Heike Liewen, Ronald de Wit, Johann de Bono, Oliver Sartor, Frank Stenner-Liewen. Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial. European Journal of Cancer 2016; 56: 93 doi: 10.1016/j.ejca.2015.12.009
|